Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives [Yahoo! Finance]
Ventyx Biosciences, Inc. (VTYX)
Company Research
Source: Yahoo! Finance
As of December 18, 2025, 90% of analysts are bullish on Ventyx Biosciences, Inc. (NASDAQ:VTYX), setting a median price target of $14.00. This translates into a massive upside potential of 82.05%. Amid this bullish momentum, Ventyx Biosciences, Inc. (NASDAQ:VTYX) was seen advancing its clinical and strategic initiatives, visible through the updates the company shared earlier in December. On December 2, 2025, Ventyx Biosciences, Inc. (NASDAQ:VTYX) announced the addition of two prominent experts: Mark McKenna as Strategic Advisor and Dr. Peter Libby as Clinical Advisor. With these additions, the company strengthened its advisory board. At the same time, Ventyx Biosciences, Inc. (NASDAQ:VTYX) shared progress in its ongoing phase 2 study of VTX2735 in patients with recurrent pericarditis. Management stated that this expanded advisory team will enable key decisions across both VTX2735 and VTX3232, the latter having already generated two positive Phase 2 data sets earlier this year.
Show less
Read more
Impact Snapshot
Event Time:
VTYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTYX alerts
High impacting Ventyx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
VTYX
News
- One Ventyx Biosciences Insider Raised Their Stake In The Previous Year [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYXPR Newswire
- Ventyx Provides Clinical and Corporate UpdatesGlobeNewswire
- Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in LondonGlobeNewswire
VTYX
Earnings
- 11/6/25 - Beat
VTYX
Sec Filings
- 12/19/25 - Form 4
- 12/19/25 - Form 4
- 12/18/25 - Form 144
- VTYX's page on the SEC website